3 results found for: EMA

European authorities approve cannabis-based medicine for epilepsy

European authorities have for the first time approved a cannabis-based medicine for use in severe childhood epilepsy.

EMA: Recalled valsartan could cause 1 extra cancer case per 5,000 patients

The European Medicines Agency has issued an update on its investigation into the health risks of taking valsartan medicines containing an impurity that may have carcinogenic potential

Some pharma companies behind on Brexit preparations

Some pharmaceutical companies have yet to prepare for Brexit, potentially impacting the distribution in Europe of over 100 medicines, the EMA has said